Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Csont, Tamás ^a,b   Sárközy, Márta ^a,b   Szcs, Gerg ^a   Szcs, Csilla ^c   Bárkányi, Judit ^c   Bencsik, Péter ^a,b   Gáspár, Renáta ^a   Földesi, Imre ^a   Csonka, Csaba ^a,b   Kónya, Csaba ^c   Ferdinandy, Péter ^b,d  

^a UNIVERSITY OF SZEGED   (Hungary)

^b PHARMAHUNGARY GROUP   (Hungary)

^c Béres Pharmaceuticals Ltd   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiovascular risk; Hypercholesterolemia; Inflammation; Multimineral; Multivitamin; Oxidative stress; Prevention

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LIPID; MINERAL; MULTIVITAMIN; PHYTOSTEROL; TRACE ELEMENT; TRIACYLGLYCEROL; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART WEIGHT; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, DIETARY; DIETARY SUPPLEMENTS; HYPERLIPIDEMIAS; INFUSION PUMPS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGAN CULTURE TECHNIQUES; PHYTOSTEROLS; RATS; RATS, WISTAR; TRIGLYCERIDES; URIC ACID; VITAMINS;

EID: 84885497266     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-138     Document Type: Article

References (36)

1. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. Kuklina EV, Yoon PW, Keenan NL, JAMA 2009 302 2104 2110 10.1001/jama.2009.1672 19920234
2. American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, Circulation 2012 125 188 197 22215894
3. Cholesterol and mortality. 30 years of follow-up from the Framingham study. Anderson KM, Castelli WP, Levy D, JAMA 1987 257 2176 2180 10.1001/jama.1987.03390160062027 3560398 (Pubitemid 17055840)
4. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack CV Jr, Gore JM, Chandra-Strobos N, Peterson ED, French WJ, Am Heart J 2008 156 1026 1034 10.1016/j.ahj.2008.07.030 19032996
5. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. Varga ZV, Kupai K, Szucs G, Gaspar R, Paloczi J, Farago N, Zvara A, Puskas LG, Razga Z, Tiszlavicz L, Bencsik P, Gorbe A, Csonka C, Ferdinandy P, Csont T, J Mol Cell Cardiol 2013 62 111 121 23722270
6. Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Csont T, Bereczki E, Bencsik P, Fodor G, Gorbe A, Zvara A, Csonka C, Puskas LG, Santha M, Ferdinandy P, Cardiovasc Res 2007 76 100 109 10.1016/j.cardiores.2007. 06.006 17658498 (Pubitemid 47362048)
7. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyorgyi R, Nagy I, Koltai M, Dux L, J Mol Cell Cardiol 1997 29 3321 3333 10.1006/jmcc.1997.0557 9441838 (Pubitemid 28039366)
8. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Ferdinandy P, Schulz R, Baxter GF, Pharmacol Rev 2007 59 418 458 10.1124/pr.107.06002 18048761
9. Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P, Chest 2005 128 1623 1628 10.1378/chest.128.3.1623 16162767 (Pubitemid 41324456)
10. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Kupai K, Csonka C, Fekete V, Odendaal L, Van Rooyen J, Marais De W, Csont T, Ferdinandy P, Am J Physiol Heart Circ Physiol 2009 297 1729 1735 10.1152/ajpheart.00484.2009 19734363
11. Beyond statins: lipid management to reduce cardiovascular risk. Schuck RN, Mendys PM, Pharmacotherapy 2013 33 754 764 10.1002/phar.1268 23606278
12. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, N Engl J Med 1987 317 1237 1245 10.1056/NEJM198711123172001 3313041 (Pubitemid 17147964)
13. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W, J Am Coll Cardiol 1986 8 1245 1255 10.1016/S0735-1097(86)80293-5 3782631 (Pubitemid 17208898)
14. Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg). Li K, Kaaks R, Linseisen J, Rohrmann S, Eur J Nutr 2012 51 407 413 10.1007/s00394-011-0224-1 21779961
15. Examination of vitamin intakes among US adults by dietary supplement use. Bailey RL, Fulgoni VL, Keast DR, Dwyer JT, J Acad Nutr Diet 2012 112 657 663 10.1016/j.jand.2012.01.026 22709770
16. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF, Am J Epidemiol 2004 160 339 349 10.1093/aje/kwh207 15286019 (Pubitemid 39045265)
17. Vitamins-dietary intake and intake from dietary supplements in Germany. Beitz R, Mensink GB, Fischer B, Thamm M, Eur J Clin Nutr 2002 56 539 545 10.1038/sj.ejcn.1601346 12032654 (Pubitemid 34649732)
18. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P, Clin Biochem 2007 40 623 628 10.1016/j.clinbiochem.2007.02. 003 17425952 (Pubitemid 46829070)
19. Niacin administration significantly reduces oxidative stress in patients with hypercholesterolemia and low levels of high-density lipoprotein cholesterol. Hamoud S, Kaplan M, Meilin E, Hassan A, Torgovicky R, Cohen R, Hayek T, Am J Med Sci 2013 345 195 199 10.1097/MAJ.0b013e3182548c28 22990043
20. Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients. Lim HJ, Choi YM, Choue R, Nutr Res 2008 28 767 774 10.1016/j.nutres.2008.08.005 19083486
21. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial. Shidfar F, Homayounfar R, Fereshtehnejad SM, Kalani A, Arch Med Res 2009 40 380 386 10.1016/j.arcmed.2009. 06.004 19766902
22. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Dabbagh AJ, Shwaery GT, Keaney JF Jr, Frei B, Arterioscler Thromb Vasc Biol 1997 17 2638 2645 10.1161/01.ATV.17.11.2638 9409237 (Pubitemid 28016003)
23. Beneficial effects of dietary copper supplementation on serum lipids and antioxidant defenses in rats. Galhardi CM, Diniz YS, Rodrigues HG, Faine LA, Burneiko RC, Ribas BO, Novelli EL, Ann Nutr Metab 2005 49 283 288 10.1159/000087294 16088091 (Pubitemid 41291549)
24. The effects of vitamin E and selenium intake on oxidative stress and plasma lipids in hamsters fed fish oil. Poirier J, Cockell K, Hidiroglou N, Madere R, Trick K, Kubow S, Lipids 2002 37 1125 1133 12617464 (Pubitemid 36236987)
25. The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. Talati R, Sobieraj DM, Makanji SS, Phung OJ, Coleman CI, J Am Diet Assoc 2010 110 719 726 10.1016/j.jada.2010.02.011 20430133
26. Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence. Laitinen K, Gylling H, Lipids Health Dis 2012 11 140 511 X-11-140 10.1186/1476-511X-11-140 23088653
27. Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study. Garaiova I, Muchova J, Nagyova Z, Mislanova C, Oravec S, Dukat A, Wang D, Plummer SF, Durackova Z, Nutr J 2013 12 7 2891 12-7 10.1186/1475-2891- 12-7 23297818
28. Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011. Off J Eur Union http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2011:304:0018:0063:EN:PDF
29. Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Csont T, Balogh G, Csonka C, Boros I, Horvath I, Vigh L, Ferdinandy P, Biochem Biophys Res Commun 2002 290 1535 1538 10.1006/bbrc.2002.6377 11820796 (Pubitemid 34687432)
30. Measurement of myocardial infarct size in preclinical studies. Csonka C, Kupai K, Kocsis GF, Novak G, Fekete V, Bencsik P, Csont T, Ferdinandy P, J Pharmacol Toxicol Methods 2010 61 163 170 10.1016/j.vascn.2010.02.014 20188845
31. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts. Kocsis GF, Pipis J, Fekete V, Kovacs-Simon A, Odendaal L, Molnar E, Giricz Z, Janaky T, van Rooyen J, Csont T, Ferdinandy P, Am J Physiol Heart Circ Physiol 2008 294 2406 2409 10.1152/ajpheart.00862.2007 18359895
32. Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats. Sarkozy M, Zvara A, Gyemant N, Fekete V, Kocsis GF, Pipis J, Szucs G, Csonka C, Puskas LG, Ferdinandy P, Csont T, Cardiovasc Diabetol 2013 12 16 12 16 23305356
33. Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide. Ferdinandy P, Csonka C, Csont T, Szilvassy Z, Dux L, Mol Cell Biochem 1998 186 27 34 10.1023/A:1006832929044 9774182 (Pubitemid 28438543)
34. Preconditioning protects the heart in a prolonged uremic condition. Kocsis GF, Sarkozy M, Bencsik P, Pipicz M, Varga ZV, Paloczi J, Csonka C, Ferdinandy P, Csont T, Am J Physiol Heart Circ Physiol 2012 303 1229 1236 10.1152/ajpheart.00379.2012 22982778
35. Role of phytosterols in lipid-lowering: current perspectives. Gupta AK, Savopoulos CG, Ahuja J, Hatzitolios AI, QJM 2011 104 301 308 10.1093/qjmed/hcr007 21325285
36. Tribulosin protects rat hearts from ischemia/reperfusion injury. Zhang S, Li H, Yang SJ, Acta Pharmacol Sin 2010 31 671 678 10.1038/aps.2010.45 20453871